Glial A30P alpha-synuclein pathology segregates neurogenesis from anxiety-related behavior in conditional transgenic mice

Neurobiology of Disease

Volumn 59, Issue , 2013, Pages 38-51

  Marxreiter, Franz ^a   Ettle, Benjamin ^a   May, Verena E L ^a   Esmer, Hakan ^b   Patrick, Christina ^c   Kragh, Christine Lund ^c,d   Klucken, Jochen ^a   Winner, Beate ^e   Riess, Olaf ^b   Winkler, Jürgen ^a,c   Masliah, Eliezer ^c,f   Nuber, Silke ^b,c  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

A30P alpha synuclein; Conditional; Gliosis; Parkinson's disease; Propagation; S100B; Transgenic

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BIOACCUMULATION; BRAIN REGION; CELL SURVIVAL; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE COURSE; GLIA CELL; HIPPOCAMPUS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE; UPREGULATION;

A30P ALPHA-SYNUCLEIN; CONDITIONAL; GLIOSIS; PARKINSON'S DISEASE; PROPAGATION; S100B; TRANSGENIC;

ALANINE; ALPHA-SYNUCLEIN; ANIMALS; ANXIETY; AVOIDANCE LEARNING; CELL COUNT; DISEASE MODELS, ANIMAL; DOXYCYCLINE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; NERVE TISSUE PROTEINS; NEUROGENESIS; NEUROGLIA; NEUROPEPTIDES; OLFACTORY BULB; PROLINE;

EID: 84881113966     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2013.07.004     Document Type: Article

References (94)

1. Anderson J.P., Walker D.E., Goldstein J.M., de Laat R., Banducci K., Caccavello R.J., Barbour R., Huang J., Kling K., Lee M., Diep L., Keim P.S., Shen X., Chataway T., Schlossmacher M.G., Seubert P., Schenk D., Sinha S., Gai W.P., Chilcote T.J. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J. Biol. Chem. 2006, 281:29739-29752.
2. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 2003, 24:197-211.
3. Braak H., Sastre M., Del Tredici K. Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease. Acta Neuropathol. 2007, 114:231-241.
4. Brandewiede J., Schachner M., Morellini F. Ethological analysis of the senescence-accelerated P/8 mouse. Behav. Brain Res. 2005, 158:109-121.
5. Brunjes P.C., Jazaeri A., Sutherland M.J. Olfactory bulb organization and development in Monodelphis domestica (grey short-tailed opossum). J. Comp. Neurol. 1992, 320:544-554.
6. Buron G., Hacquemand R., Pourie G., Lucarz A., Jacquot L., Brand G. Comparative behavioral effects between synthetic 2,4,5-trimethylthiazoline (TMT) and the odor of natural fox (Vulpes vulpes) feces in mice. Behav. Neurosci. 2007, 121:1063-1072.
7. Cabin D.E., Gispert-Sanchez S., Murphy D., Auburger G., Myers R.R., Nussbaum R.L. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background. Neurobiol. Aging 2005, 26:25-35.
8. Chandrasekaran K., Hazelton J.L., Wang Y., Fiskum G., Kristian T. Neuron-specific conditional expression of a mitochondrially targeted fluorescent protein in mice. J. Neurosci. Off. J. Soc. Neurosci. 2006, 26:13123-13127.
9. Chen Y., Miles D.K., Hoang T., Shi J., Hurlock E., Kernie S.G., Lu Q.R. The basic helix-loop-helix transcription factor olig2 is critical for reactive astrocyte proliferation after cortical injury. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28:10983-10989.
10. Choi W., Zibaee S., Jakes R., Serpell L.C., Davletov B., Crowther R.A., Goedert M. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. FEBS Lett. 2004, 576:363-368.
11. Conway K.A., Harper J.D., Lansbury P.T. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease. Nat. Med. 1998, 4:1318-1320.
12. Conway K.A., Harper J.D., Lansbury P.T. Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 2000, 39:2552-2563.
13. Conway K.A., Lee S.J., Rochet J.C., Ding T.T., Williamson R.E., Lansbury P.T. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:571-576.
14. Crupi R., Cambiaghi M., Spatz L., Hen R., Thorn M., Friedman E., Vita G., Battaglia F. Reduced adult neurogenesis and altered emotional behaviors in autoimmune-prone B-cell activating factor transgenic mice. Biol. Psychiatry 2010, 67:558-566.
15. Cuervo A.M., Stefanis L., Fredenburg R., Lansbury P.T., Sulzer D. Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 2004, 305:1292-1295.
16. Desplats P., Lee H.J., Bae E.J., Patrick C., Rockenstein E., Crews L., Spencer B., Masliah E., Lee S.J. Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13010-13015.
17. Ebrahimi-Fakhari D., Cantuti-Castelvetri I., Fan Z., Rockenstein E., Masliah E., Hyman B.T., McLean P.J., Unni V.K. Distinct roles in vivo for the ubiquitin-proteasome system and the autophagy-lysosomal pathway in the degradation of alpha-synuclein. J. Neurosci. Off. J. Soc. Neurosci. 2011, 31:14508-14520.
18. Eisch A.J., Petrik D. Depression and hippocampal neurogenesis: a road to remission?. Science 2012, 338:72-75.
19. Ekdahl C.T., Claasen J.H., Bonde S., Kokaia Z., Lindvall O. Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13632-13637.
20. Erondu N.E., Kennedy M.B. Regional distribution of type II Ca2+/calmodulin-dependent protein kinase in rat brain. J. Neurosci. Off. J. Soc. Neurosci. 1985, 5:3270-3277.
21. George S., van den Buuse M., San Mok S., Masters C.L., Li Q.X., Culvenor J.G. Alpha-synuclein transgenic mice exhibit reduced anxiety-like behaviour. Exp. Neurol. 2008, 210:788-792.
22. Glinka M.E., Samuels B.A., Diodato A., Teillon J., Feng Mei D., Shykind B.M., Hen R., Fleischmann A. Olfactory deficits cause anxiety-like behaviors in mice. J. Neurosci. 2012, 32:6718-6725.
23. Glynn D., Bortnick R.A., Morton A.J. Complexin II is essential for normal neurological function in mice. Hum. Mol. Genet. 2003, 12:2431-2448.
24. Gu X.L., Long C.X., Sun L., Xie C., Lin X., Cai H. Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice. Mol. Brain 2010, 3:12.
25. Gundersen H.J., Bendtsen T.F., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., Sorensen F.B., Vesterby A., et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988, 96:379-394.
26. Hansen C., Angot E., Bergstrom A.L., Steiner J.A., Pieri L., Paul G., Outeiro T.F., Melki R., Kallunki P., Fog K., Li J.Y., Brundin P. alpha-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells. J. Clin. Invest. 2011, 121:715-725.
27. Hasegawa M., Fujiwara H., Nonaka T., Wakabayashi K., Takahashi H., Lee V.M., Trojanowski J.Q., Mann D., Iwatsubo T. Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions. J. Biol. Chem. 2002, 277:49071-49076.
28. Hebb A.L., Zacharko R.M., Gauthier M., Trudel F., Laforest S., Drolet G. Brief exposure to predator odor and resultant anxiety enhances mesocorticolimbic activity and enkephalin expression in CD-1 mice. Eur. J. Neurosci. 2004, 20:2415-2429.
29. Hejjaoui M., Haj-Yahya M., Kumar K.S., Brik A., Lashuel H.A. Towards elucidation of the role of ubiquitination in the pathogenesis of Parkinson's disease with semisynthetic ubiquitinated alpha-synuclein. Angew. Chem. Int. Ed. Engl. 2011, 50:405-409.
30. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Luthi A. Neuronal circuits of fear extinction. Eur. J. Neurosci. 2010, 31:599-612.
31. Hodgson T.L., Dittrich W.H., Henderson L., Kennard C. Eye movements and spatial working memory in Parkinson's disease. Neuropsychologia 1999, 37:927-938.
32. Hoglinger G.U., Rizk P., Muriel M.P., Duyckaerts C., Oertel W.H., Caille I., Hirsch E.C. Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci. 2004, 7:726-735.
33. Jang A., Lee H.J., Suk J.E., Jung J.W., Kim K.P., Lee S.J. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions. J. Neurochem. 2010, 113:1263-1274.
34. Kohl Z., Winner B., Ubhi K., Rockenstein E., Mante M., Munch M., Barlow C., Carter T., Masliah E., Winkler J. Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model. Eur. J. Neurosci. 2012, 35:10-19.
35. Kordower J.H., Chu Y., Hauser R.A., Freeman T.B., Olanow C.W. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease. Nat. Med. 2008, 14:504-506.
36. Lee M.K., Stirling W., Xu Y., Xu X., Qui D., Mandir A.S., Dawson T.M., Copeland N.G., Jenkins N.A., Price D.L. Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53->Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:8968-8973.
37. Lee H.J., Patel S., Lee S.J. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J. Neurosci. Off. J. Soc. Neurosci. 2005, 25:6016-6024.
38. Lee H.J., Suk J.E., Patrick C., Bae E.J., Cho J.H., Rho S., Hwang D., Masliah E., Lee S.J. Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J. Biol. Chem. 2010, 285:9262-9272.
39. Lee S., Kim W., Li Z., Hall G.F. Accumulation of vesicle-associated human tau in distal dendrites drives degeneration and tau secretion in an in situ cellular tauopathy model. Int. J. Alzheimers Dis. 2012, 2012:172837.
40. Lee S.J., Sigurdson C., Tsigelny I., Masliah E., Lee S.J., Sigurdson C., Tsigelny I., Masliah E. Pathological propagation through cell-to-cell transmission of non-prion protein aggregates in neurodegenerative disorders 2013, (submitted for publication).
41. Li J., Uversky V.N., Fink A.L. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 2001, 40:11604-11613.
42. Li J., Uversky V.N., Fink A.L. Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. Neurotoxicology 2002, 23:553-567.
43. Li J.Y., Englund E., Holton J.L., Soulet D., Hagell P., Lees A.J., Lashley T., Quinn N.P., Rehncrona S., Bjorklund A., Widner H., Revesz T., Lindvall O., Brundin P. Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation. Nat. Med. 2008, 14:501-503.
44. Lim Y., Kehm V.M., Lee E.B., Soper J.H., Li C., Trojanowski J.Q., Lee V.M. alpha-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies. J. Neurosci. Off. J. Soc. Neurosci. 2011, 31:10076-10087.
45. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. Off. J. Soc. Neurosci. 1999, 19:10428-10437.
46. Lu J., Esposito G., Scuderi C., Steardo L., Delli-Bovi L.C., Hecht J.L., Dickinson B.C., Chang C.J., Mori T., Sheen V. S100B and APP promote a gliocentric shift and impaired neurogenesis in Down syndrome neural progenitors. PLoS One 2011, 6:e22126.
47. Luk K.C., Kehm V., Carroll J., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 2012, 338:949-953.
48. Luk K.C., Kehm V.M., Zhang B., O'Brien P., Trojanowski J.Q., Lee V.M. Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. J. Exp. Med. 2012, 209:975-986.
49. Marchese A., Paing M.M., Temple B.R., Trejo J. G protein-coupled receptor sorting to endosomes and lysosomes. Annu. Rev. Pharmacol. Toxicol. 2008, 48:601-629.
50. Mariggio M.A., Fulle S., Calissano P., Nicoletti I., Fano G. The brain protein S-100ab induces apoptosis in PC12 cells. Neuroscience 1994, 60:29-35.
51. Martins-Branco D., Esteves A.R., Santos D., Arduino D.M., Swerdlow R.H., Oliveira C.R., Januario C., Cardoso S.M. Ubiquitin proteasome system in Parkinson's disease: a keeper or a witness?. Exp. Neurol. 2012, 238:89-99.
52. Marxreiter F., Nuber S., Kandasamy M., Klucken J., Aigner R., Burgmayer R., Couillard-Despres S., Riess O., Winkler J., Winner B. Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synuclein. Eur. J. Neurosci. 2009, 29:879-890.
53. May V.E., Nuber S., Marxreiter F., Riess O., Winner B., Winkler J. Impaired olfactory bulb neurogenesis depends on the presence of human wild-type alpha-synuclein. Neuroscience 2012, 222:343-355.
54. Mayford M., Bach M.E., Huang Y.Y., Wang L., Hawkins R.D., Kandel E.R. Control of memory formation through regulated expression of a CaMKII transgene. Science 1996, 274:1678-1683.
55. Mayford M., Mansuy I.M., Muller R.U., Kandel E.R. Memory and behavior: a second generation of genetically modified mice. Curr. Biol. 1997, 7:R580-R589.
56. Mirescu C., Gould E. Stress and adult neurogenesis. Hippocampus 2006, 16:233-238.
57. Monje M.L., Toda H., Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 2003, 302:1760-1765.
58. Morgane P.J., Galler J.R., Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog. Neurobiol. 2005, 75:143-160.
59. Mougenot A.L., Nicot S., Bencsik A., Morignat E., Verchere J., Lakhdar L., Legastelois S., Baron T. Prion-like acceleration of a synucleinopathy in a transgenic mouse model. Neurobiol. Aging 2012, 33:2225-2228.
60. Narhi L., Wood S.J., Steavenson S., Jiang Y., Wu G.M., Anafi D., Kaufman S.A., Martin F., Sitney K., Denis P., Louis J.C., Wypych J., Biere A.L., Citron M. Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation. J. Biol. Chem. 1999, 274:9843-9846.
61. Neumann M., Kahle P.J., Giasson B.I., Ozmen L., Borroni E., Spooren W., Muller V., Odoy S., Fujiwara H., Hasegawa M., Iwatsubo T., Trojanowski J.Q., Kretzschmar H.A., Haass C. Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies. J. Clin. Invest. 2002, 110:1429-1439.
62. Nonaka T., Hasegawa M. A cellular model to monitor proteasome dysfunction by alpha-synuclein. Biochemistry 2009, 48:8014-8022.
63. Nuber S., Petrasch-Parwez E., Winner B., Winkler J., von Horsten S., Schmidt T., Boy J., Kuhn M., Nguyen H.P., Teismann P., Schulz J.B., Neumann M., Pichler B.J., Reischl G., Holzmann C., Schmitt I., Bornemann A., Kuhn W., Zimmermann F., Servadio A., Riess O. Neurodegeneration and motor dysfunction in a conditional model of Parkinson's disease. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28:2471-2484.
64. Nuber S., Petrasch-Parwez E., Arias-Carrion O., Koch L., Kohl Z., Schneider J., Calaminus C., Dermietzel R., Samarina A., Boy J., Nguyen H.P., Teismann P., Velavan T.P., Kahle P.J., von Horsten S., Fendt M., Kruger R., Riess O. Olfactory neuron-specific expression of A30P alpha-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiol. Dis. 2011, 44:192-204.
65. Oaks A.W., Frankfurt M., Finkelstein D.I., Sidhu A. Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function. PLoS One 2013, 8:e60378.
66. Owen A.M., Beksinska M., James M., Leigh P.N., Summers B.A., Marsden C.D., Quinn N.P., Sahakian B.J., Robbins T.W. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993, 31:627-644.
67. Parekh A.B. Mitochondrial regulation of intracellular Ca2+ signaling: more than just simple Ca2+ buffers. News Physiol. Sci. 2003, 18:252-256.
68. Petrik D., Lagace D.C., Eisch A.J. The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building?. Neuropharmacology 2012, 62:21-34.
69. Petrucelli L., O'Farrell C., Lockhart P.J., Baptista M., Kehoe K., Vink L., Choi P., Wolozin B., Farrer M., Hardy J., Cookson M.R. Parkin protects against the toxicity associated with mutant alpha-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 2002, 36:1007-1019.
70. Pillon B., Ertle S., Deweer B., Sarazin M., Agid Y., Dubois B. Memory for spatial location is affected in Parkinson's disease. Neuropsychologia 1996, 34:77-85.
71. Revest J.M., Dupret D., Koehl M., Funk-Reiter C., Grosjean N., Piazza P.V., Abrous D.N. Adult hippocampal neurogenesis is involved in anxiety-related behaviors. Mol. Psychiatry 2009, 14:959-967.
72. Rideout H.J., Larsen K.E., Sulzer D., Stefanis L. Proteasomal inhibition leads to formation of ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells. J. Neurochem. 2001, 78:899-908.
73. Rothermundt M., Peters M., Prehn J.H., Arolt V. S100B in brain damage and neurodegeneration. Microsc. Res. Tech. 2003, 60:614-632.
74. Rott R., Szargel R., Haskin J., Bandopadhyay R., Lees A.J., Shani V., Engelender S. alpha-Synuclein fate is determined by USP9X-regulated monoubiquitination. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:18666-18671.
75. Russo S.J., Murrough J.W., Han M.H., Charney D.S., Nestler E.J. Neurobiology of resilience. Nat. Neurosci. 2012, 15:1475-1484.
76. Schneider B.L., Seehus C.R., Capowski E.E., Aebischer P., Zhang S.C., Svendsen C.N. Over-expression of alpha-synuclein in human neural progenitors leads to specific changes in fate and differentiation. Hum. Mol. Genet. 2007, 16:651-666.
77. Snyder H., Mensah K., Theisler C., Lee J., Matouschek A., Wolozin B. Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function. J. Biol. Chem. 2003, 278:11753-11759.
78. Snyder J.S., Soumier A., Brewer M., Pickel J., Cameron H.A. Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 2011, 476:458-461.
79. Song C., Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci. Biobehav. Rev. 2005, 29:627-647.
80. Song H., Stevens C.F., Gage F.H. Astroglia induce neurogenesis from adult neural stem cells. Nature 2002, 417:39-44.
81. Tanapat P., Galea L.A., Gould E. Stress inhibits the proliferation of granule cell precursors in the developing dentate gyrus. Int. J. Dev. Neurosci. 1998, 16:235-239.
82. Tatsumi K., Takebayashi H., Manabe T., Tanaka K.F., Makinodan M., Yamauchi T., Makinodan E., Matsuyoshi H., Okuda H., Ikenaka K., Wanaka A. Genetic fate mapping of Olig2 progenitors in the injured adult cerebral cortex reveals preferential differentiation into astrocytes. J. Neurosci. Res. 2008, 86:3494-3502.
83. Tofaris G.K., Layfield R., Spillantini M.G. alpha-synuclein metabolism and aggregation is linked to ubiquitin-independent degradation by the proteasome. FEBS Lett. 2001, 509:22-26.
84. Tofaris G.K., Garcia Reitbock P., Humby T., Lambourne S.L., O'Connell M., Ghetti B., Gossage H., Emson P.C., Wilkinson L.S., Goedert M., Spillantini M.G. Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders. J. Neurosci. 2006, 26:3942-3950.
85. Tsika E., Moysidou M., Guo J., Cushman M., Gannon P., Sandaltzopoulos R., Giasson B.I., Krainc D., Ischiropoulos H., Mazzulli J.R. Distinct region-specific alpha-synuclein oligomers in A53T transgenic mice: implications for neurodegeneration. J. Neurosci. Off. J. Soc. Neurosci. 2010, 30:3409-3418.
86. Ubhi K., Inglis C., Mante M., Patrick C., Adame A., Spencer B., Rockenstein E., May V., Winkler J., Masliah E. Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of alpha-synucleinopathy. Exp. Neurol. 2012, 234:405-416.
87. Walz W. Controversy surrounding the existence of discrete functional classes of astrocytes in adult gray matter. Glia 2000, 31:95-103.
88. Wang D., Noda Y., Tsunekawa H., Zhou Y., Miyazaki M., Senzaki K., Nabeshima T. Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety. Behav. Brain Res. 2007, 178:262-273.
89. Wang L., Xie C., Greggio E., Parisiadou L., Shim H., Sun L., Chandran J., Lin X., Lai C., Yang W.J., Moore D.J., Dawson T.M., Dawson V.L., Chiosis G., Cookson M.R., Cai H. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J. Neurosci. Off. J. Soc. Neurosci. 2008, 28:3384-3391.
90. Wilcock D.M., Vitek M.P., Colton C.A. Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease. Neuroscience 2009, 159:1055-1069.
91. Winner B., Lie D.C., Rockenstein E., Aigner R., Aigner L., Masliah E., Kuhn H.G., Winkler J. Human wild-type alpha-synuclein impairs neurogenesis. J. Neuropathol. Exp. Neurol. 2004, 63:1155-1166.
92. Winner B., Rockenstein E., Lie D.C., Aigner R., Mante M., Bogdahn U., Couillard-Despres S., Masliah E., Winkler J. Mutant alpha-synuclein exacerbates age-related decrease of neurogenesis. Neurobiol. Aging 2008, 29:913-925.
93. Winner B., Regensburger M., Schreglmann S., Boyer L., Prots I., Rockenstein E., Mante M., Zhao C., Winkler J., Masliah E., Gage F.H. Role of alpha-synuclein in adult neurogenesis and neuronal maturation in the dentate gyrus. J. Neurosci. Off. J. Soc. Neurosci. 2012, 32:16906-16916.
94. Zhou D., Masliah E., Spector S.A. Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. J. Infect. Dis. 2011, 203:1647-1657.